Jiangzhong pharmaceutical: it is estimated that the total operating revenue in the first quarter of 2022 will be about 890 million yuan, with a year-on-year increase of about 30%

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

Jiuri New Materials and Partners Plan Acquisition of Dutch Photoinitiator Business IGM

Jiuri New Materials（久日新材）said on November 10 that it and six co-investors plan to acquire the Dutch holding company behind photoinitiator producer IGM Resins. The transaction has an estimated total purchase price of approximately EUR 251 million, including refinancing and deferred consideration.

Cambridge Industries Group Plans Optical Module Capacity Expansion Across Four Countries

Cambridge Industries Group（剑桥科技）, or CIG, reaffirmed plans to add at least 10 million units of annual high-speed optical module capacity by the end of 2027. The expanded capacity will be allocated across production sites in China, Malaysia, Mexico and the United States.

Vital Optics Unit Signs InP Substrate Supply Letter of Intent with Coherent

Vital Optics（光智科技）said on November 6 that its controlling subsidiary Guangdong Xianrui Technology（广东先锐科技）had signed a long-term supply letter of intent with Coherent Corp.（高意）. The proposed supply of six-inch indium phosphide substrates from 2027 to 2029 has an estimated transaction value of no less than USD 601 million.

CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM

There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?